// App-Quantinova.ai

3143 : Global Trends in Hematopoietic Cell Transplantation.

Researchers

Presenter

  • Mahmoud Aljurf

Principal Investigators

  • Luis Fernando Bouzas

  • Adriana Seber

  • Jeffrey Szer

  • Dietger Niederwieser

  • Alois Gratwohl

  • Yoshihisa Kodera

  • Jeff H Lipton

  • J. Alejandro Madrigal

  • Lida Minako

  • Nicolas Novitzky

  • Marcelo C Pasquini

  • Jakob R. Passweg

Medical Centers

  • Radiation Oncology, University of Leipzig, Leipzig, Germany

  • Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

  • University of Cape Town Leukemia Unit, Department of Medicine (Haematology) and National Health Laboratory Services (Haematology), University of Cape Town, Groote Schuur Hospital and National Health Laboratory Services, Cape Town, South Africa

  • Clinical Haematology and Bone Transplant Service, Royal Melbourne Hospital, Victoria, Australia

  • The Royal Free Hospital, The Anthony Nolan Rsch. Inst., London, United Kingdom

  • Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan

  • Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Behandlungszentrum Stammzelltransplantation, Universitatsspital Basel, Basel, Switzerland

  • Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan

  • Hematology & Stem Cell Transplant Unit, University Hospital Basel, Basel, Switzerland

  • Haematology, University Hospital, Basel, Switzerland

  • Instituto Nacional de Cancer - INCA, Rio De Janeiro, Brazil

  • Inst De Oncologia Pediatrica, Sao Paulo, Brazil

Locations

  • Brazil

  • Canada

  • Saudi Arabia

  • Japan

  • Germany

  • United Kingdom

  • Switzerland

  • Australia

  • South Africa

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lympho proliferative disease

  • Chronic Lymphocytic Leukemia

  • Chronic Myelogenous Leukemia

  • Myelodysplastic Syndrome

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved